These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3438619)

  • 1. Confirmatory analysis of survival data using left truncation of the life times of primary survivors.
    Keiding N; Bayer T; Watt-Boolsen S
    Stat Med; 1987 Dec; 6(8):939-44. PubMed ID: 3438619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
    van Tienhoven G; Voogd AC; Peterse JL; Nielsen M; Andersen KW; Mignolet F; Sylvester R; Fentiman IS; van der Schueren E; van Zijl K; Blichert-Toft M; Bartelink H; van Dongen JA
    Eur J Cancer; 1999 Jan; 35(1):32-8. PubMed ID: 10211085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer.
    Haybittle JL; Brinkley D; Houghton J; A'Hern RP; Baum M
    BMJ; 1989 Jun; 298(6688):1611-4. PubMed ID: 2503148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.
    Ejlertsen B; Offersen BV; Overgaard J; Christiansen P; Jensen MB; Kroman N; Knoop AS; Mouridsen H
    Acta Oncol; 2018 Jan; 57(1):3-12. PubMed ID: 29205077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal censoring and the sequential logrank procedure.
    Richardson DJ
    Stat Med; 1992 Jul; 11(10):1359-66. PubMed ID: 1518996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis-generating and confirmatory studies, Bonferroni correction, and pre-specification of trial endpoints.
    Ranstam J
    Acta Orthop; 2019 Aug; 90(4):297. PubMed ID: 31084234
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of logrank tests and group sequential methods at fixed calendar times.
    DeMets DL; Gail MH
    Biometrics; 1985 Dec; 41(4):1039-44. PubMed ID: 4096915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing complex group sequential survival trials.
    Lakatos E
    Stat Med; 2002 Jul; 21(14):1969-89. PubMed ID: 12111882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in the design and interpretation of clinical trials.
    Pocock SJ
    Br Med J (Clin Res Ed); 1985 Jan; 290(6461):39-42. PubMed ID: 3917328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methodology of controlled clinical studies on the primary treatment of operable breast cancer].
    Scheurlen H; Olschewski M; Leibbrand D
    Strahlentherapie; 1984 Aug; 160(8):459-68. PubMed ID: 6474519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angina clinical trial methodology.
    Ford I
    Postgrad Med J; 1991; 67 Suppl 3():S2-8. PubMed ID: 1758828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method for studying survival rate rate product, variance and significance test.
    Tang DL; Quan RJ
    Chin Med J (Engl); 1983 Oct; 96(10):777-82. PubMed ID: 6426875
    [No Abstract]   [Full Text] [Related]  

  • 13. Performing serial testing of treatment effects.
    Fleming TR; Green SJ; Harrington DP
    Experientia Suppl; 1982; 41():469-84. PubMed ID: 6958531
    [No Abstract]   [Full Text] [Related]  

  • 14. Do estimates of long-term survival tell us whether patients diagnosed with breast cancer before age 50 years are ever cured?
    Green S
    J Clin Oncol; 2004 Feb; 22(3):392-4. PubMed ID: 14691128
    [No Abstract]   [Full Text] [Related]  

  • 15. Alternative approaches to evaluating the impact of local control on survival.
    Lee JY; Bedwinek JM; Fineberg BB; Ocwieza MA
    Am J Clin Oncol; 1982 Jun; 5(3):281-4. PubMed ID: 7081146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.
    Cobleigh MA; Berris RF; Bush T; Davidson NE; Robert NJ; Sparano JA; Tormey DC; Wood WC
    JAMA; 1994 Aug; 272(7):540-5. PubMed ID: 8046809
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient heterogeneity in clinical trials.
    Simon R
    Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample sizes based on the log-rank statistic in complex clinical trials.
    Lakatos E
    Biometrics; 1988 Mar; 44(1):229-41. PubMed ID: 3358991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact that group sequential tests would have made on ECOG clinical trials.
    Rosner GL; Tsiatis AA
    Stat Med; 1989 Apr; 8(4):505-16. PubMed ID: 2657957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of survival in cancer clinical trials.
    Shimm D; Logue G
    Ann Intern Med; 1983 May; 98(5 Pt 1):665-6. PubMed ID: 6846980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.